Drug General Information (ID: DDIGE7914P)
  Drug Name Ergometrine Drug Info Amyl Nitrite Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Oxytocics Antidotes
  Structure

 Mechanism of Ergometrine-Amyl Nitrite Interaction (Severity Level: Moderate)
     Antagonize the effect of antihypertensive agents Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Ergometrine Amyl Nitrite
      Mechanism Hypertensive effects Hypotensive effects
Guanylate cyclase  Agonist
      Key Mechanism Factor 1
Factor Name Guanylate cyclase soluble Structure Sequence
Protein Family Adenylyl cyclase class-4/guanylyl cyclase family
Protein Function
There are two types of guanylate cyclases: soluble forms and membrane-associated receptor forms. Activated by nitric oxide in the presence of magnesium or manganese ions.
    Click to Show/Hide
      Mechanism Description
  • Antagonize the effect of Ergometrine when combined with Amyl Nitrite 

Recommended Action
      Management This combination should generally be avoided. Ergot alkaloids are considered contraindicated in patients with ischemic heart disease.

References
1 Product Information. D.H.E. 45 (dihydroergotamine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
2 Raberger G, Schutz W, Zimpfer M, Kraupp O "The influence of dihydroergotamine on adenosine-induced and reactive coronary vasodilation. Interaction of dihydroergotamine and coronary vasodilation." Basic Res Cardiol 71 (1976): 645-51
3 Bobik A, Jennings G, Skews H, Esler M, McLean A "Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with orthostatic hypotension." Clin Pharmacol Ther 30 (1981): 673-9